The NF-κB pathway is activated by SREBP, a transcription factor that mediates the anabolism of cholesterol and lipids, and then inhibits apoptosis, and boosts the proliferation and resistance to progesterone of endometrial cancer cells. This evidence concerns the gene NFKB1 and endometrial cancer.